Functional split and crosslinking of the membrane domain of the beta subunit of proton-translocating transhydrogenase from Escherichia coli. 2003

Magnus Althage, and Jenny Karlsson, and Pontus Gourdon, and Mikael Levin, and Roslyn M Bill, and Anna Tigerström, and Jan Rydström
Department of Biochemistry and Biophysics, Göteborg University, Sweden.

Proton pumping nicotinamide nucleotide transhydrogenase from Escherichia coli contains an alpha subunit with the NAD(H)-binding domain I and a beta subunit with the NADP(H)-binding domain III. The membrane domain (domain II) harbors the proton channel and is made up of the hydrophobic parts of the alpha and beta subunits. The interface in domain II between the alpha and the beta subunits has previously been investigated by cross-linking loops connecting the four transmembrane helices in the alpha subunit and loops connecting the nine transmembrane helices in the beta subunit. However, to investigate the organization of the nine transmembrane helices in the beta subunit, a split was introduced by creating a stop codon in the loop connecting transmembrane helices 9 and 10 by a single mutagenesis step, utilizing an existing downstream start codon. The resulting enzyme was composed of the wild-type alpha subunit and the two new peptides beta1 and beta2. As compared to other split membrane proteins, the new transhydrogenase was remarkably active and catalyzed activities for the reduction of 3-acetylpyridine-NAD(+) by NADPH, the cyclic reduction of 3-acetylpyridine-NAD(+) by NADH (mediated by bound NADP(H)), and proton pumping, amounting to about 50-107% of the corresponding wild-type activities. These high activities suggest that the alpha subunit was normally folded, followed by a concerted folding of beta1 + beta2. Cross-linking of a betaS105C-betaS237C double cysteine mutant in the functional split cysteine-free background, followed by SDS-PAGE analysis, showed that helices 9, 13, and 14 were in close proximity. This is the first time that cross-linking between helices in the same beta subunit has been demonstrated.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009243 NAD A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed) Coenzyme I,DPN,Diphosphopyridine Nucleotide,Nadide,Nicotinamide-Adenine Dinucleotide,Dihydronicotinamide Adenine Dinucleotide,NADH,Adenine Dinucleotide, Dihydronicotinamide,Dinucleotide, Dihydronicotinamide Adenine,Dinucleotide, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide,Nucleotide, Diphosphopyridine
D009249 NADP Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) Coenzyme II,Nicotinamide-Adenine Dinucleotide Phosphate,Triphosphopyridine Nucleotide,NADPH,Dinucleotide Phosphate, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide Phosphate,Nucleotide, Triphosphopyridine,Phosphate, Nicotinamide-Adenine Dinucleotide
D009250 NADP Transhydrogenases Enzymes that catalyze the reversible reduction of NAD by NADPH to yield NADP and NADH. This reaction permits the utilization of the reducing properties of NADPH by the respiratory chain and in the reverse direction it allows the reduction of NADP for biosynthetic purposes. NADP Transhydrogenase,Pyridine Nucleotide Transhydrogenase,Energy-Linked Transhydrogenase,NAD Transhydrogenase,NADPH NAD Transhydrogenase,NADPH Transferase,Nicotinamide Nucleotide Transhydrogenase,Energy Linked Transhydrogenase,NAD Transhydrogenase, NADPH,Nucleotide Transhydrogenase, Nicotinamide,Nucleotide Transhydrogenase, Pyridine,Transferase, NADPH,Transhydrogenase, Energy-Linked,Transhydrogenase, NAD,Transhydrogenase, NADP,Transhydrogenase, NADPH NAD,Transhydrogenase, Nicotinamide Nucleotide,Transhydrogenase, Pyridine Nucleotide,Transhydrogenases, NADP
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011510 Proteolipids Protein-lipid combinations abundant in brain tissue, but also present in a wide variety of animal and plant tissues. In contrast to lipoproteins, they are insoluble in water, but soluble in a chloroform-methanol mixture. The protein moiety has a high content of hydrophobic amino acids. The associated lipids consist of a mixture of GLYCEROPHOSPHATES; CEREBROSIDES; and SULFOGLYCOSPHINGOLIPIDS; while lipoproteins contain PHOSPHOLIPIDS; CHOLESTEROL; and TRIGLYCERIDES.

Related Publications

Magnus Althage, and Jenny Karlsson, and Pontus Gourdon, and Mikael Levin, and Roslyn M Bill, and Anna Tigerström, and Jan Rydström
September 1995, Biochemical and biophysical research communications,
Magnus Althage, and Jenny Karlsson, and Pontus Gourdon, and Mikael Levin, and Roslyn M Bill, and Anna Tigerström, and Jan Rydström
July 1995, The Journal of biological chemistry,
Magnus Althage, and Jenny Karlsson, and Pontus Gourdon, and Mikael Levin, and Roslyn M Bill, and Anna Tigerström, and Jan Rydström
July 2005, Biochimica et biophysica acta,
Magnus Althage, and Jenny Karlsson, and Pontus Gourdon, and Mikael Levin, and Roslyn M Bill, and Anna Tigerström, and Jan Rydström
September 1977, Biochemistry,
Magnus Althage, and Jenny Karlsson, and Pontus Gourdon, and Mikael Levin, and Roslyn M Bill, and Anna Tigerström, and Jan Rydström
July 2004, The Journal of biological chemistry,
Magnus Althage, and Jenny Karlsson, and Pontus Gourdon, and Mikael Levin, and Roslyn M Bill, and Anna Tigerström, and Jan Rydström
January 2001, Biochemical and biophysical research communications,
Magnus Althage, and Jenny Karlsson, and Pontus Gourdon, and Mikael Levin, and Roslyn M Bill, and Anna Tigerström, and Jan Rydström
November 2004, Biochimica et biophysica acta,
Magnus Althage, and Jenny Karlsson, and Pontus Gourdon, and Mikael Levin, and Roslyn M Bill, and Anna Tigerström, and Jan Rydström
September 2005, Journal of molecular biology,
Magnus Althage, and Jenny Karlsson, and Pontus Gourdon, and Mikael Levin, and Roslyn M Bill, and Anna Tigerström, and Jan Rydström
August 1991, Biochemical Society transactions,
Copied contents to your clipboard!